SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea · Delayed Price · Currency is KRW 1,522.00
-1.00 (-0.07%)
Jan 22, 2026, 3:30 PM KST
SAMSUNG PHARM. Co., LTD. Market Cap
SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 143.25 billion as of January 22, 2026. Its market cap has decreased by -1.68% in one year.
Market Cap
143.25B
Enterprise Value
n/a
Revenue
44.29B
Ranking
n/a
PE Ratio
11.27
Stock Price
1,522.00
Market Cap Chart
Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 143.25B, an increase of 700.97%. That is a compound annual growth rate of 7.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 143.25B | -0.52% |
| Dec 30, 2025 | 144.00B | -0.52% |
| Dec 30, 2024 | 144.76B | -0.84% |
| Dec 28, 2023 | 145.99B | -18.99% |
| Dec 29, 2022 | 180.22B | -45.48% |
| Dec 30, 2021 | 330.57B | -11.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 88.92T |
| Celltrion | 45.18T |
| ALTEOGEN | 26.53T |
| ABL Bio | 10.84T |
| SK Biopharmaceuticals | 9.26T |
| Yuhan | 7.91T |
| HLB Co., Ltd. | 6.83T |
| Sam Chun Dang Pharm. | 6.43T |